Literature DB >> 24011921

Neuroprotective effect of tadalafil, a PDE-5 inhibitor, and its modulation by L-NAME in mouse model of ischemia-reperfusion injury.

Puja Gulati1, Nirmal Singh.   

Abstract

BACKGROUND: The present study investigates the neuroprotective effect of tadalafil, a selective phosphodiesterase-5 inhibitor, in a mouse model of ischemia-reperfusion injury.
MATERIALS AND METHODS: Bilateral carotid artery occlusion for 12 min followed by reperfusion for 24 h was employed to produce ischemia-reperfusion-induced cerebral injury in male Swiss mice. Cerebral infarct size was measured using triphenyltetrazolium chloride staining. Memory was assessed using Morris water maze test. Degree of motor incoordination was evaluated using inclined beam walk test, rota-rod test, and lateral push test. Brain nitrite/nitrate, brain acetylcholinesterase activity, brain thiobarbituric acid reactive species, and glutathione levels were also estimated.
RESULTS: Bilateral carotid artery occlusion, followed by reperfusion, produced a significant rise in cerebral infarct size, brain nitrite/nitrate levels, acetylcholinesterase activity, and thiobarbituric acid reactive species level along with a fall in glutathione. A significant impairment of memory and motor coordination was also noted. Pretreatment of tadalafil significantly attenuated the above effects of ischemia-reperfusion injury. Tadalafil-induced neuroprotective effects were significantly attenuated by administration of L-NAME, a nonselective nitric oxide synthase inhibitor.
CONCLUSIONS: Results indicate that tadalafil exerts neuroprotective effects, probably through nitric oxide-dependent pathways. Therefore, phosphodiesterase-5 can be explored as an important target to contain ischemia-reperfusion injury.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebral ischemia; L-NAME; Memory; Neuroprotection; Nitric oxide; Tadalafil

Mesh:

Substances:

Year:  2013        PMID: 24011921     DOI: 10.1016/j.jss.2013.08.005

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  11 in total

1.  Involvement of NO-cGMP pathway in anti-hyperalgesic effect of PDE5 inhibitor tadalafil in experimental hyperalgesia.

Authors:  K V Otari; C D Upasani
Journal:  Inflammopharmacology       Date:  2015-07-10       Impact factor: 4.473

2.  5-HMF attenuates striatum oxidative damage via Nrf2/ARE signaling pathway following transient global cerebral ischemia.

Authors:  Bai-Liu Ya; Hong-Fang Li; Hai-Ying Wang; Fei Wu; Qing Xin; Hong-Ju Cheng; Wen-Juan Li; Na Lin; Zai-Hua Ba; Ru-Juan Zhang; Qian Liu; Ya-Nan Li; Bo Bai; Feng Ge
Journal:  Cell Stress Chaperones       Date:  2016-11-03       Impact factor: 3.667

3.  Suppression of renal TRPM7 may alleviate kidney injury in the renal transplantation.

Authors:  Zhe Meng; Rui Cao; Yongzhi Wang; Hong Cao; Tao Liu; Zhonghua Yang; Xinghuan Wang
Journal:  World J Urol       Date:  2013-11-21       Impact factor: 4.226

4.  Roflumilast and tadalafil improve learning and memory deficits in intracerebroventricular Aβ1-42 rat model of Alzheimer's disease through modulations of hippocampal cAMP/cGMP/BDNF signaling pathway.

Authors:  Noorul Hasan; Saima Zameer; Abul Kalam Najmi; Suhel Parvez; Mohammad Shahar Yar; Mohd Akhtar
Journal:  Pharmacol Rep       Date:  2021-04-15       Impact factor: 3.024

Review 5.  Implications of Phosphoinositide 3-Kinase-Akt (PI3K-Akt) Pathway in the Pathogenesis of Alzheimer's Disease.

Authors:  Manish Kumar; Nitin Bansal
Journal:  Mol Neurobiol       Date:  2021-10-26       Impact factor: 5.682

6.  Effect of co-administration of BRL-37344 and tadalafil on reduction of overactive bladder symptoms after induction of detrusor overactivity in mice1.

Authors:  Marcos Fiuza de Carvalho; Thuliermes Lopes Pamplona; Márcio Alencar Barreira; Francisco Vagnaldo Jacuru Fechine; Lúcio Flávio Gonzaga-Silva; Ricardo Reges Maia de Oliveira
Journal:  Acta Cir Bras       Date:  2019-02-28       Impact factor: 1.388

7.  Maternal tadalafil therapy for fetal growth restriction prevents non-alcoholic fatty liver disease and adipocyte hypertrophy in the offspring.

Authors:  Takuya Kawamura; Hiroaki Tanaka; Ryota Tachibana; Kento Yoshikawa; Shintaro Maki; Kuniaki Toriyabe; Hiroki Takeuchi; Shinji Katsuragi; Kayo Tanaka; Tomoaki Ikeda
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 8.  Sildenafil-Mediated Neuroprotection from Adult to Neonatal Brain Injury: Evidence, Mechanisms, and Future Translation.

Authors:  Manuela Zinni; Julien Pansiot; Pierre-Louis Léger; Marina El Kamouh; Olivier Baud
Journal:  Cells       Date:  2021-10-15       Impact factor: 6.600

Review 9.  ROCK and PDE-5 Inhibitors for the Treatment of Dementia: Literature Review and Meta-Analysis.

Authors:  Dong-Hun Lee; Ji Young Lee; Dong-Yong Hong; Eun Chae Lee; Sang-Won Park; Yu Na Jo; Yu Jin Park; Jae Young Cho; Yoo Jin Cho; Su Hyun Chae; Man Ryul Lee; Jae Sang Oh
Journal:  Biomedicines       Date:  2022-06-08

10.  Physical exercise prevents motor disorders and striatal oxidative imbalance after cerebral ischemia-reperfusion.

Authors:  P M Sosa; H L Schimidt; C Altermann; A S Vieira; F W S Cibin; F P Carpes; P B Mello-Carpes
Journal:  Braz J Med Biol Res       Date:  2015-07-28       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.